L. Ondrisova

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL

J. Strefford, H. Parker, K. Potter, 2022, Blood advances.

Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies

M. Mraz, Laura Ondrisova, L. Ondrisova, 2020, Frontiers in Oncology.

miR-29 Modulates CD40 Signaling in Chronic Lymphocytic Leukemia by Targeting TRAF4: an Axis Affected by BCR inhibitors.

U. Jaeger, L. Rassenti, T. Kipps, 2020, Blood.

FoxO1-GAB1 Axis Regulates Homing Capacity and Tonic AKT Activity in Chronic Lymphocytic Leukemia.

V. Beneš, Shuxing Zhang, Š. Pospíšilová, 2021, Blood.

Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugs

Š. Pospíšilová, A. Hampl, J. Jaros, 2024, Leukemia.